![Akshay Sharma, Corey Luellen, his parents](/content/sites/www/en_US/home/about-st-jude/stories/making-a-difference/patient-story-corey/jcr:content/par-1/cnt_image.img.16.medium.jpg/1707250903213.jpg)
Dr. Akshay Sharma, Corey Luellen, and Corey's parents, Crystal Boxley and Timothty Washington.
“I love St. Jude, and I trust them with my life,” said Corey Luellen, who was treated at St. Jude for sickle cell disease. Sickle cell disease causes regular pain crises, as well as organ damage. Luellen was born with a mutation in the gene for the oxygen-carrying molecule hemoglobin. That single mutation causes red blood cells to take on a C or sickled shape and causes them to get stuck in narrow blood vessels. These clogged vessels are what cause problems throughout the body.
At St. Jude, Luellen had a special opportunity: to participate in a clinical trial of a new type of treatment for sickle cell disease. He was one of a handful of patients enrolled in the study that used gene editing to treat the condition at the DNA level. Gene editing for sickle cell disease is on the cutting edge of science-informed therapy and is a major focus of research at St. Jude.
How did the experimental treatment go for Luellen? The number of pain crises that Luellen has had has decreased dramatically. In the two years since he received gene therapy, he was only admitted for a pain crisis once.
![Akshay Sharma and Corey Luellen](/content/sites/www/en_US/home/about-st-jude/stories/making-a-difference/patient-story-corey/jcr:content/par-1/cnt_image_1465421233.img.16.medium.jpg/1707501875477.jpg)
“I haven’t had a blood transfusion in two years, and that’s kind of amazing,” Luellen said. Prior to treatment, he was receiving monthly transfusions to manage his symptoms. “I was always feeling down. I can tell the difference; I do feel better. I feel like I can do things more freely now.”
The key to his choice to participate in clinical research was thinking about the future.
“I was thinking about my health really long term because I know sickle cell is a long-term disease,” Luellen said. “The problems I was having, I just didn’t want them to get worse as I got older.”
Throughout the study, another motivation emerged: helping other sickle cell patients. Rather than seeing the trial as just a treatment for him individually, Luellen came to see it as his opportunity to assist those struggling with the same condition. His participation advanced medicine one step closer to curing sickle cell disease.
“I got a chance to help somebody else who’s going through the same thing or who went through worse,” Luellen said. “I’m happy I did it because I got the chance to help somebody else, even though their disease may be different. I got a chance to help the next person.”
Read more patient stories
-
Research may help Camille take her first steps
Research conducted by the Center for Experimental Neurotherapeutics may help patients like Camille, who has type 2 spinal muscular atrophy, gain the ability to walk.
-
Insights Learned Through Cancer Experience Now Help Others
St. Jude survivor Tristan Elsener has survived multiple bouts of cancer. He and his family have gained insights that can help others. Learn about the Caregivers Share podcast.
-
Patient finds support, help and hope for Friedrich’s ataxia
Taylor Hurdle is taking part in a clinical trial for Friedreich’s ataxia at St. Jude Children’s Research Hospital.
-
Patient reflects on 60th anniversary as childhood cancer survivor
Patient reflects on her 60th anniversary as a childhood cancer survivor
-
Challenges Can’t Keep Jolly Down
Jolly Green tackles severe aplastic anemia thanks to St. Jude, faith, and family. Read his story.
-
Finding Hope in Clinical Trials
A medulloblastoma clinical trial offered hope to 7-year-old Kinlee Johnson and her family. Learn more.
-
From Pain Crises to Good Vibes
Rashawn Hendrix
-
Family chooses St. Jude because of SAMD9/SAMD9L researcher
Family chooses St. Jude for care because of its expertise in SAMD9/SAMD9L syndrome.
-
Molecular diagnostics give Fletcher what some thought impossible: a diagnosis and treatment plan
Molecular diagnostics give Fletcher Fazenbaker what some thought impossible: a diagnosis and treatment plan for infant-type hemispheric glioma (IHG), a subtype of high-grade glioma — a rare brain tumor — that was not classified by the World Health Organization’s brain tumor classification guide until 2021
-
Surviving childhood cancer is just the beginning of Darshana’s story
Darshana Magan survived cancer 30 years ago, but her treatment caused long-term health issues. Read how she cares for her health and encourages other survivors.
-
Sickle cell disease education and support help Jayden excel
Jayden's care team at St. Jude is helping him manage and understand his sickle cell disease. Learn more
-
Scan-tastic! St. Jude helps Zara succeed
St. Jude child life specialists help patients understand the MRI scanning process to make it easier for them, and some patients are able to stay still enough for scans that anesthesia isn't needed.
-
Teen climbs new heights after bone cancer
Doctors at St. Jude Children's Research Hospital were able to save Micah Winkle's leg from bone cancer, but it was up to the teen to discover alternatives to the contact sports he had played before his cancer diagnosis. Find out more.
-
Limiting the side effects of treatment: Proton Therapy provides focused radiation
St. Jude has the world’s first proton therapy center dedicated to childhood cancer. Patients come from all over to receive treatment. One such patient is Brianna Gonzales.
Careers
At St. Jude, your career makes a difference. We offer outstanding opportunities in the basic and translational sciences, clinical research, patient care and many other areas for talented individuals.